| Biotechnology feed | All feeds
- Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com Alkermes, Inc.
- Pharmaceuticals & Healthcare - Deals and Alliances Profile... PR inside: Mar 10 2010 9:44PM Matching: vivitrol Find similar documents
Alkermes, Inc.
- Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information.
The profile examines the companys key business... PR inside: Mar 10 2010 9:39PM Matching: vivitrol Find similar documents
(NASDAQ:AAPL) zoomed 2.25% to $224.02 and made a new 52-week high at $224.48Apple Inc.
(Apple) designs,... Earthtimes.org: Mar 9 2010 7:44PM Matching: vivitrol Find similar documents
(ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 30th Annual Health Care Conference on Monday, March 8, 2010, at 2:30 p.m.
ET from the Boston Marriott Copley Place.
The presentation may be... Boston Globe: Mar 3 2010 2:07AM Matching: vivitrol Find similar documents
- (BUSINESS WIRE) - Alkermes, Inc.
(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 30th Annual Health Care Conference on Monday, March 8, 2010, at 2:30 p.m.
ET from the Boston... NewsBlaze: Mar 3 2010 1:06AM Matching: vivitrol Find similar documents
ET from the... EON: Mar 2 2010 11:29PM Matching: vivitrol Find similar documents
ET from the Boston... Yahoo! Canada: Mar 2 2010 11:17PM Matching: vivitrol Find similar documents
WALTHAM, Mass.
-- (BUSINESS WIRE) -- Alkermes, Inc.
(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 30th Annual Health Care Conference on... Freshnews.com: Mar 2 2010 10:04PM Matching: vivitrol Find similar documents
(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 30th Annual Health Care Conference on... Freshnews.com: Mar 2 2010 10:03PM Matching: vivitrol Find similar documents
ET from the Boston Marriott Copley Place.... Centre Daily Times: Mar 2 2010 9:44PM Matching: vivitrol Find similar documents
- (Business Wire) Alkermes, Inc.
ET from the Boston... Earthtimes.org: Mar 2 2010 9:22PM Matching: vivitrol Find similar documents
(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 30 th Annual Health Care Conference on Monday, March 8, 2010, at 2:30 p.m.
ET from the Boston... PR inside: Mar 2 2010 9:17PM Matching: vivitrol Find similar documents
The... PR inside: Mar 2 2010 9:16PM Matching: vivitrol Find similar documents
(AP) ' Biotechnology company Cephalon Inc.
said Thursday its fourth-quarter profit surged on a boost in sales and lower charges.
Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago,... PharmaceuticalProcessing: Feb 13 2010 3:29PM Matching: vivitrol Find similar documents
said yesterday that its fourth-quarter profit surged on a boost in sales and lower charges.
Frazer-based Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when... Philadelphia Inquirer: Feb 12 2010 8:56PM Matching: vivitrol Find similar documents
Frazer-based Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when... Philadelphia Inquirer: Feb 12 2010 3:55PM Matching: vivitrol Find similar documents
Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when the company... Bioscience Technology Online: Feb 12 2010 12:20AM Matching: vivitrol Find similar documents
Biotechnology company Cephalon Inc.
Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when the... DCExaminer.com: Feb 11 2010 11:33PM Matching: vivitrol Find similar documents
(NasdaqGS: ALKS - News) with a price target of $11.50.
Alkermes is a drug delivery biotech company which uses its proprietary specialized... Cafepharma: Feb 10 2010 9:52AM Matching: vivitrol Find similar documents
(ALKS) with a price target of $11.50.
Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop drugs for the treatment of central nervous system... Individual.com: Feb 9 2010 1:26PM Matching: vivitrol Find similar documents
(ALKS - Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop drugs for the treatment of central nervous system (CNS) disorders, alcoholism and... Zacks.com: Feb 9 2010 3:12AM Matching: vivitrol Find similar documents
( ALKS ) with a price target of $11.50.
Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop drugs for the treatment of central nervous... Benzinga.com: Feb 8 2010 10:09PM Matching: vivitrol Find similar documents
(NASDAQ: ALKS - News) today reported financial results for its third quarter of fiscal 2010, which ended on December 31, 2009.
Financial highlights: Quarterly revenues of $44.2 million, driven by record manufacturing and royalty... Business Wire via Yahoo!: Feb 4 2010 10:07PM Matching: vivitrol Find similar documents
(NASDAQ: ALKS) will host a conference call at 4:30 p.m.
ET on Thursday, February 4, 2010, to discuss the company's financial results for the third quarter of fiscal 2010.
Management will review the quarter and provide an update on the... Pharma Live: Jan 29 2010 3:11PM Matching: vivitrol Find similar documents
(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 13, 2010 at 8:30 a.m.
PT (11:30 a.m.
ET) from the Westin St.
Francis Hotel in... Business Wire via Yahoo!: Jan 6 2010 9:03PM Matching: vivitrol Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
